Angina News and Research

RSS
Angina is chest pain or discomfort that occurs when an area of your heart muscle doesn't get enough oxygen-rich blood. Angina may feel like pressure or squeezing in your chest. The pain also may occur in your shoulders, arms, neck, jaw, or back. It can feel like indigestion.
Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Gilead Sciences second-quarter total revenues increase 17% to $1.93 billion

Gilead Sciences second-quarter total revenues increase 17% to $1.93 billion

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

Women with serious form of angina have higher risk of developing CAD: Researchers

Women with serious form of angina have higher risk of developing CAD: Researchers

Older men with high testosterone levels more likely to have heart attacks

Older men with high testosterone levels more likely to have heart attacks

Bayer signs agreement to supply Adalat XL product to Teva Canada

Bayer signs agreement to supply Adalat XL product to Teva Canada

Mylan granted final FDA approval for Procardia XL Tablets

Mylan granted final FDA approval for Procardia XL Tablets

Merck's DULERA Inhalation Aerosol for asthma receives FDA approval

Merck's DULERA Inhalation Aerosol for asthma receives FDA approval

Health Diagnostic Laboratory announces new capability to run CYP2C19 genetic test

Health Diagnostic Laboratory announces new capability to run CYP2C19 genetic test

Anthera commences enrollment in pivotal VISTA-16 Phase 3 clinical study of varespladib

Anthera commences enrollment in pivotal VISTA-16 Phase 3 clinical study of varespladib

Cardiogenesis' shares quoted on newly launched OTCQB market

Cardiogenesis' shares quoted on newly launched OTCQB market

Women who experience early menopause may have cardiovascular disease later in life: Study

Women who experience early menopause may have cardiovascular disease later in life: Study

Preliminary top-line results from Hematide Phase 3 program for anemia in chronic renal failure patients

Preliminary top-line results from Hematide Phase 3 program for anemia in chronic renal failure patients

GE Healthcare highlights molecular imaging technologies to help clinicians improve patient experiences

GE Healthcare highlights molecular imaging technologies to help clinicians improve patient experiences

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Vaso Healthcare, GE Healthcare sign sales representative agreement

Vaso Healthcare, GE Healthcare sign sales representative agreement

Volcano to highlight extensive pipeline of imaging and therapy products at EuroPCR 2010

Volcano to highlight extensive pipeline of imaging and therapy products at EuroPCR 2010

PLC Systems' RenalGuard to be showcased at EuroPCR 2010

PLC Systems' RenalGuard to be showcased at EuroPCR 2010

Arizona's smoking ban reduces hospital admissions for stroke, asthma and angina

Arizona's smoking ban reduces hospital admissions for stroke, asthma and angina

VIA-2291 can reduce inflammation in patients with atherosclerosis: Study

VIA-2291 can reduce inflammation in patients with atherosclerosis: Study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.